Target intelligence / Profile preview

SNX29 antisense RNA 3 (SNX29-AS3)

Target
SNX29-AS3
Molecular classification
Long non-coding RNA, Natural antisense transcript, Antisense RNA
01

Overview

SNX29 antisense RNA 3 (SNX29-AS3) is a non-coding RNA transcribed from the strand opposite the SNX29 gene locus, and is categorized as a long non-coding RNA natural antisense transcript (NAT), also known as antisense RNA. Antisense RNAs like SNX29-AS3 typically regulate the expression of their sense gene (in this case SNX29, Sorting nexin 29) through complementary base pairing to SNX29 mRNA, leading to inhibition of transcript translation, degradation of target mRNA, or local chromatin and epigenetic modification. The precise biological function and disease associations of SNX29-AS3 are not well-characterized; the majority of known research is on the SNX29 protein-coding gene, which has roles in lipid metabolism, reproduction, and neurodevelopment[1][3][4][2][6]. There are no known approved drugs or clinical biomarkers directly associated with SNX29-AS3. Notes on correctness: SNX29-AS3 does not appear to be a classical "therapeutic target" such as a receptor, enzyme, or transporter. Instead, it is a non-coding regulatory RNA. Current biomedical research on SNX29 mainly focuses on the protein-coding gene and not on specific antisense RNAs; published information on "SNX29 antisense RNA 3" is lacking, and there is no evidence that it is a well-established molecular target for drugs or diagnostics. This entry is largely inferential and its status as a canonical or validated locus is uncertain. If more detailed structural or functional data are needed, the SNX29 gene/protein itself should be considered.

Other names
SNX29-AS3SNX29 antisense RNA 3antisense transcript of SNX29
02

Mechanism of action

Regulation of mRNA stability or translation by RNA-RNA hybridization; may recruit chromatin modifiers for epigenetic changes

03

Biological functions

Regulation of SNX29 gene expression (by complementarity to SNX29 mRNA)Epigenetic regulationTranscriptional regulation
04

Disease associations

None specifically known; SNX29 gene is implicated in neuropsychiatric and reproductive traits, but no direct disease association for SNX29-AS3 found

Beyond the preview

Go deeper on SNX29 antisense RNA 3 (SNX29-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNX29 antisense RNA 3 (SNX29-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call